Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Urinary Bladder Neoplasms 2Neoplasms 2Lung Neoplasms 2Disease 2Colorectal Neoplasms 2Acute Kidney Injury 2Tuberous Sclerosis 1Spinal Cord Injuries 1Smoldering Multiple Myeloma 1Salivary Gland Adenoma, Pleomorphic 1Renal Insufficiency 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Monoclonal Gammopathy of Undetermined Significance 1Lymphangioleiomyomatosis 1Liver Cirrhosis 1Kidney Neoplasms 1Hematologic Neoplasms 1Hemangiosarcoma 1Glioma 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

rimabotulinumtoxinB 1Urination 1OM 89 1Neurofeedback 1Negative-Pressure Wound Therapy 1N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide 1Music Therapy 1Cholecalciferol 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinal Cord Injuries × Urination × Clear all
NCT02538809 2025-02-13

Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

Swiss Paraplegic Research, Nottwil

Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Spinal Cord Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡